Study of differences in the VEGFR2 inhibitory activities between semaxanib and SU5205 using 3D-QSAR, docking, and molecular dynamics simulations-Reference-Cited by-同舟云学术

Study of differences in the VEGFR2 inhibitory activities between semaxanib and SU5205 using 3D-QSAR, docking, and molecular dynamics simulations

Published:2012-02 Issue: Volume:32 Page:39-48
ISSN:1093-3263
Container-title:Journal of Molecular Graphics and Modelling
language:en
Short-container-title:Journal of Molecular Graphics and Modelling

Author:

Muñoz Camila,Adasme Francisco,Alzate-Morales Jans H.,Vergara-Jaque Ariela,Kniess Torsten,Caballero Julio

Publisher

Elsevier BV

Subject

Materials Chemistry,Computer Graphics and Computer-Aided Design,Physical and Theoretical Chemistry,Spectroscopy

Reference48 articles.

1. The angiogenesis inhibitor SU5416 has long-lasting effects on vascular endothelial growth factor receptor phosphorylation and function;Mendel;Clin. Cancer Res.,2000

2. The hallmarks of cancer;Hanahan;Cell,2000

3. Targeted in vivo imaging of angiogenesis: present status and perspectives;Yearn;Curr. Pharm. Des.,2007

4. Synthesis and radiopharmacological investigation of 3-[4′-[18F]fluorobenzylidene]indolin-2-one as possible tyrosine kinase inhibitor;Kniess;Bioorg. Med. Chem.,2009

5. Insights into the structural basis of N2 and O6 substituted guanine derivatives as cyclin-dependent kinase 2 (CDK2) inhibitors: prediction of the binding modes and potency of the inhibitors by docking and ONIOM calculations;Alzate-Morales;J. Chem. Inf. Model.,2009

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Machine Learning Modeling Predicting Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) Inhibitors Structure-Activity Relationships Using Quantum DFT Descriptors;2023 XLIX Latin American Computer Conference (CLEI);2023-10-16

2. Computational study of the binding orientation and affinity of noncovalent inhibitors of the papain-like protease (PLpro) from SARS-CoV-1 considering the protein flexibility by using molecular dynamics and cross-docking;Frontiers in Molecular Biosciences;2023-06-23

3. Computational Chemistry for the Identification of Lead Compounds for Radiotracer Development;Pharmaceuticals;2023-02-18

4. Discovery and Design of Radiopharmaceuticals by In silico Methods;Current Radiopharmaceuticals;2022-12

5. A novel twelve-gene signature to predict neoadjuvant chemotherapy response and prognosis in breast cancer;Frontiers in Immunology;2022-10-19